Position in AMGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$424,404
+$9,925 QoQ
Shares Held
1,172
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#2,297
of 3,140 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fortitude Family Office, LLC holds $6,252,480 across 11 Drug Manufacturers - General names. AMGN ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,046 | $3,653,464 | |
| 2 | ABBV |
AbbVie Inc.
|
4,225 | $1,063,179 | |
| 3 | JNJ |
Johnson & Johnson
|
1,844 | $468,320 | |
| 4 | AMGN |
Amgen Inc
This page
|
1,172 | $424,404 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,950 | $379,075 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
690 | $87,174 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,205 | $69,432 | |
| 8 | BIIB |
Biogen Inc.
|
315 | $68,058 |
All Filings in AMGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $424,404 | 1,172 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $414,479 | 1,178 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $853,297 | 2,607 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $728,076 | 2,580 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $720,082 | 2,579 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $811,276 | 2,604 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $695,387 | 2,668 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $851,923 | 2,644 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $608,340 | 1,947 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $466,569 | 1,641 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $472,640 | 1,641 | Shares | Sole | 2024-01-12 | |
| No filing history on record for this holder in this stock. | ||||||